The North America Microwave Ablation Market should witness market growth of 13.3% CAGR during the forecast period (2022-2028).
Microwaves have the capability of propagating through as well as effectively heating larger volumes of tissues of different types including those with low electrical & thermal conductivity and high impedance. For instance, bone & lung tissues are linked with suboptimal outcomes with radiofrequency because of their high baseline impedance. Similar to RF & laser technologies, microwave ablation technology could readily penetrate via desiccated or charred tissues that are inclined to build up around hyperthermic ablation applicators, which results in limited power delivery to non-microwave energy systems.
More than one microwave antenna could be used together to get the benefit of thermal synergy if placed in widely spaced or close proximity to ablate various tumors in one go. Although multi-applicator ablation is also possible through other power sources, microwave ablation has the ability to power continuously without the need to switch from one electrode to another.
Microwave ablation includes the utilization of a generator that produces an electromagnetic field that is transmitted by an antenna that causes friction and agitation among water molecules which raises the tissues’ temperature up to 60-150°C. If compared to radiofrequency ablation, microwave ablation offers various advantages, including lower heat sink interference, higher temperature production capacity, unaffected by the high impedance of multiple tissues, and less time to be spent for large areas of ablation.
In the United States, HIV is still a public health problem. There were approximately 30,635 people in 2020 who underwent HIV diagnosis in the United States and the rest of the region. This could further result in the rising prevalence of HIV cases. In 2019, in the United States, around 1,752,735 new cases were diagnosed, and about 439 new cancer cases out of every 100,000 people in the region. This rising occurrence of cancer raises the demand for advanced technologies for the treatment of cancer. This would boost the demand for ablation technologies, thereby supporting the market expansion for microwave ablation in the region.
The US market dominated the North America Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $182,193.1 Thousands by 2028. The Canada market is experiencing a CAGR of 15.9% during (2022-2028). Additionally, The Mexico market would exhibit a CAGR of 14.9% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
Microwaves have the capability of propagating through as well as effectively heating larger volumes of tissues of different types including those with low electrical & thermal conductivity and high impedance. For instance, bone & lung tissues are linked with suboptimal outcomes with radiofrequency because of their high baseline impedance. Similar to RF & laser technologies, microwave ablation technology could readily penetrate via desiccated or charred tissues that are inclined to build up around hyperthermic ablation applicators, which results in limited power delivery to non-microwave energy systems.
More than one microwave antenna could be used together to get the benefit of thermal synergy if placed in widely spaced or close proximity to ablate various tumors in one go. Although multi-applicator ablation is also possible through other power sources, microwave ablation has the ability to power continuously without the need to switch from one electrode to another.
Microwave ablation includes the utilization of a generator that produces an electromagnetic field that is transmitted by an antenna that causes friction and agitation among water molecules which raises the tissues’ temperature up to 60-150°C. If compared to radiofrequency ablation, microwave ablation offers various advantages, including lower heat sink interference, higher temperature production capacity, unaffected by the high impedance of multiple tissues, and less time to be spent for large areas of ablation.
In the United States, HIV is still a public health problem. There were approximately 30,635 people in 2020 who underwent HIV diagnosis in the United States and the rest of the region. This could further result in the rising prevalence of HIV cases. In 2019, in the United States, around 1,752,735 new cases were diagnosed, and about 439 new cancer cases out of every 100,000 people in the region. This rising occurrence of cancer raises the demand for advanced technologies for the treatment of cancer. This would boost the demand for ablation technologies, thereby supporting the market expansion for microwave ablation in the region.
The US market dominated the North America Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $182,193.1 Thousands by 2028. The Canada market is experiencing a CAGR of 15.9% during (2022-2028). Additionally, The Mexico market would exhibit a CAGR of 14.9% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
Scope of the Study
By End-user
- Hospital
- Research Laboratories
- Ambulatory Surgical Centers
By Component
- Accessories
- Generator
- Power Distribution System
By Application
- Oncology
- Cardiology
- Urology
- Orthopedic
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Varian Medical Systems, Inc. (Siemens Healthineers AG)
- AngioDynamics, Inc.
- Medtronic PLC
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Terumo Corporation
- Emblation Limited
- HUBER+SUHNER AG
- MedWaves, Inc.
- SympleSurgical, Inc.
- Mermaid Medical Group
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Microwave Ablation Market by End-user
Chapter 5. North America Microwave Ablation Market by Component
Chapter 6. North America Microwave Ablation Market by Application
Chapter 7. North America Microwave Ablation Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Varian Medical Systems, Inc. (Siemens Healthineers AG)
- AngioDynamics, Inc.
- Medtronic PLC
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Terumo Corporation
- Emblation Limited
- HUBER+SUHNER AG
- MedWaves, Inc.
- SympleSurgical, Inc.
- Mermaid Medical Group
Methodology
LOADING...
